These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 26851117)
21. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Zhang ZJ Life Sci; 2004 Aug; 75(14):1659-99. PubMed ID: 15268969 [TBL] [Abstract][Full Text] [Related]
22. [Anxiety and depression. Differential diagnosis and treatment in daily practice]. Lambert PA; de Maximy B Sem Hop Ther; 1976 Nov; 52(9):501-3. PubMed ID: 12570 [No Abstract] [Full Text] [Related]
23. Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials. Miroddi M; Calapai G; Navarra M; Minciullo PL; Gangemi S J Ethnopharmacol; 2013 Dec; 150(3):791-804. PubMed ID: 24140586 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomic assessment of herbal drugs in affective disorders. Sahoo S; S B Biomed Pharmacother; 2019 Jan; 109():1148-1162. PubMed ID: 30551365 [TBL] [Abstract][Full Text] [Related]
25. The effects of a standardized Acanthopanax koreanum extract on stress-induced behavioral alterations in mice. Jung JM; Park SJ; Lee YW; Lee HE; Hong SI; Lew JH; Hong E; Shim JS; Cheong JH; Ryu JH J Ethnopharmacol; 2013 Jul; 148(3):826-34. PubMed ID: 23721913 [TBL] [Abstract][Full Text] [Related]
26. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models. Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753 [TBL] [Abstract][Full Text] [Related]
27. Designing new treatments for depression and anxiety. Chen Z; Yang J; Tobak A IDrugs; 2008 Mar; 11(3):189-97. PubMed ID: 18311656 [TBL] [Abstract][Full Text] [Related]
28. Depression and Treatment with Effective Herbs. Fathinezhad Z; Sewell RDE; Lorigooini Z; Rafieian-Kopaei M Curr Pharm Des; 2019; 25(6):738-745. PubMed ID: 30947651 [TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of the clinical effectiveness of traditional Chinese medicine formula Chaihu-Shugan-San in depression. Wang Y; Fan R; Huang X J Ethnopharmacol; 2012 Jun; 141(2):571-7. PubMed ID: 21933701 [TBL] [Abstract][Full Text] [Related]
31. [Chronobiological similarity of the specific activity of anxiolytic and antidepressant drugs]. Arushanian EB; Beĭer EV Eksp Klin Farmakol; 2007; 70(5):52-8. PubMed ID: 18074809 [TBL] [Abstract][Full Text] [Related]
32. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Huffman JC; Smith FA; Blais MA; Beiser ME; Januzzi JL; Fricchione GL Am J Cardiol; 2006 Aug; 98(3):319-24. PubMed ID: 16860016 [TBL] [Abstract][Full Text] [Related]
33. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action. Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259 [TBL] [Abstract][Full Text] [Related]
34. Characterization of the anxiolytic activity of Nunavik Rhodiola rosea. Cayer C; Ahmed F; Filion V; Saleem A; Cuerrier A; Allard M; Rochefort G; Merali Z; Arnason JT Planta Med; 2013 Oct; 79(15):1385-91. PubMed ID: 23975866 [TBL] [Abstract][Full Text] [Related]
35. Plants used in the traditional medicine of Mesoamerica (Mexico and Central America) and the Caribbean for the treatment of obesity. Alonso-Castro AJ; Domínguez F; Zapata-Morales JR; Carranza-Álvarez C J Ethnopharmacol; 2015 Dec; 175():335-45. PubMed ID: 26410815 [TBL] [Abstract][Full Text] [Related]
36. Depression & Anxiety-SMi Conference. Shining light into dark corners. 12-13 May 2003, London, UK. Durrance A IDrugs; 2003 Jul; 6(7):664-7. PubMed ID: 12908452 [No Abstract] [Full Text] [Related]
37. Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders. Singh SK; Barreto GE; Aliev G; Echeverria V Curr Drug Metab; 2017; 18(2):112-119. PubMed ID: 27908257 [TBL] [Abstract][Full Text] [Related]
38. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Sarris J; LaPorte E; Schweitzer I Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405 [TBL] [Abstract][Full Text] [Related]
39. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression. Lindemann L; Porter RH; Scharf SH; Kuennecke B; Bruns A; von Kienlin M; Harrison AC; Paehler A; Funk C; Gloge A; Schneider M; Parrott NJ; Polonchuk L; Niederhauser U; Morairty SR; Kilduff TS; Vieira E; Kolczewski S; Wichmann J; Hartung T; Honer M; Borroni E; Moreau JL; Prinssen E; Spooren W; Wettstein JG; Jaeschke G J Pharmacol Exp Ther; 2015 Apr; 353(1):213-33. PubMed ID: 25665805 [TBL] [Abstract][Full Text] [Related]
40. [Association between anxiolytic and antidepressant consumption and psychiatric symptoms in the elderly]. Alonso Formento E; Saz Muñoz P; Lobo Satué A; Ventura Faci T; De La Cámara Izquierdo C; Marcos Aragüés G Rev Esp Geriatr Gerontol; 2010; 45(1):10-4. PubMed ID: 20044171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]